Olema Pharmaceuticals Valuation
| OLMA Stock | USD 12.62 0.36 2.77% |
At this time, the company appears to be undervalued. Olema Pharmaceuticals holds a recent Real Value of $14.55 per share. The prevailing price of the company is $12.62. Our model determines the value of Olema Pharmaceuticals from analyzing the company fundamentals such as Return On Equity of -0.56, shares owned by institutions of 96.38 %, and Shares Outstanding of 57.27 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Olema Pharmaceuticals' valuation include:
Price Book 3.2722 | Enterprise Value 506.2 M | Enterprise Value Ebitda (3.33) |
Undervalued
Today
Please note that Olema Pharmaceuticals' price fluctuation is somewhat reliable at this time. Calculation of the real value of Olema Pharmaceuticals is based on 3 months time horizon. Increasing Olema Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Olema Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Olema Stock. However, Olema Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 12.62 | Real 14.55 | Target 22.0 | Hype 12.73 |
The real value of Olema Stock, also known as its intrinsic value, is the underlying worth of Olema Pharmaceuticals Company, which is reflected in its stock price. It is based on Olema Pharmaceuticals' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Olema Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Olema Pharmaceuticals helps investors to forecast how Olema stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Olema Pharmaceuticals more accurately as focusing exclusively on Olema Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Olema Pharmaceuticals' intrinsic value based on its ongoing forecasts of Olema Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Olema Pharmaceuticals' closest peers. If more than one evaluation category is relevant for Olema Pharmaceuticals we suggest using both methods to arrive at a better estimate.
Olema Pharmaceuticals Cash |
|
Olema Valuation Trend
Comparing Olema Pharmaceuticals' enterprise value against its market capitalization is a good way to estimate the value of Olema Pharmaceuticals uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Olema Pharmaceuticals Total Value Analysis
Olema Pharmaceuticals is now expected to have valuation of 506.18 M with market capitalization of 743.32 M, debt of 2.42 M, and cash on hands of 240.71 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Olema Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
506.18 M | 743.32 M | 2.42 M | 240.71 M |
Olema Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Olema is to check how much profit was generated for every dollar of assets it reports. Olema Pharmaceuticals holds a negative application of assets of -0.35 pct., losing $0.003547 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Olema Pharmaceuticals shows how discouraging it operates for each dollar spent on its assets.Olema Pharmaceuticals Ownership Allocation
The majority of Olema Pharmaceuticals outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Olema Pharmaceuticals to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Olema Pharmaceuticals. Please pay attention to any change in the institutional holdings of Olema Pharmaceuticals as this could imply that something significant has changed or is about to change at the company.Olema Pharmaceuticals Profitability Analysis
Net Loss for the year was (96.66 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Olema Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Olema Pharmaceuticals and how it compares across the competition.
About Olema Pharmaceuticals Valuation
The stock valuation mechanism determines Olema Pharmaceuticals' current worth on a weekly basis. Our valuation model uses a comparative analysis of Olema Pharmaceuticals. We calculate exposure to Olema Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Olema Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -377 K | -395.9 K |
Olema Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 45.2 M |
Olema Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of Olema Pharmaceuticals and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Olema we look at many different elements of the entity such as Olema's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Olema Pharmaceuticals' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Olema Pharmaceuticals' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Olema Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Olema Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Olema Pharmaceuticals' worth.Complementary Tools for Olema Stock analysis
When running Olema Pharmaceuticals' price analysis, check to measure Olema Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Olema Pharmaceuticals is operating at the current time. Most of Olema Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Olema Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Olema Pharmaceuticals' price. Additionally, you may evaluate how the addition of Olema Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Global Correlations Find global opportunities by holding instruments from different markets |